Treatment

Shifting landscapes, changing realities

published: March, 31, 2018 Written by // Rob Olver - Editor Categories // Aging, Activism, Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Pets, International , Treatment, Living with HIV, Media, Opinion Pieces, Rob Olver - Editor

Rob Olver on a labour of love: "Thank you PositiveLite.com. It's been a stellar ride and the lessons learned will go to good use."

Shifting landscapes, changing realities

"All your so-hard facts, painted thinly on the void; Why were you not more pleasantly employed?" -- "Puppet Song", The Incredible String Band,. At this point, the news about PositiveLite.com has been out for a few days and as you might imagine, it’s been a bit of an emotional time here at the palatial PositiveLite Editing Suite. For a long time I’ve had various ideas about how I might want to write my final blog post here, but now that the time has come, I find myself not wanting to

PositiveLite.com to end publishing March 31

published: March, 28, 2018 Written by // Bob Leahy - Publisher Categories // African, Caribbean and Black, Activism, Social Media, Aging, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, International , Treatment, Living with HIV, Media, Bob Leahy - Publisher

Bob Leahy on the history of a unique Canadian website by and for people living with HIV – and why it has run its course

PositiveLite.com to end publishing March 31

I need to share with you that PositiveLite.com will cease publishing on March 31. As its publisher I’m not sad but proud, because its nine year history has been one of a series of successes. And I don’t feel the least bit defeated now but rather going out on a high note and ending our run on our own terms. This has been in the works for some time. It’s been a struggle to keep it a secret. The reasons for closing our doors are essentially twofold. First, the people who bring you Positiv

Is the end of HIV in sight? Yes! And no.

published: March, 27, 2018 Written by // Jeff Potts Categories // Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Health, Sexual Health, Treatment, Media, Opinion Pieces, Jeff Potts

In which Jeff Potts checks in and introduces a brilliant article, "Is the End of HIV In Sight? Yes! And No" by his brother, David.

Is the end of HIV in sight? Yes! And no.

Several weeks of intensely meaningful engagement, and then this… by Jeff Potts I muse, as I tidy up this third and final draft, that it is a bit odd for a guy who lives with HIV and who works in the HIV sector (almost always has) to reflect on and write about a few weeks of full-on HIV engagement immersion.  But, that’s the truth of it.  I’m a bit weary this Monday morning as we near the end of March (and fiscal year-end).  It’s a good weary though.  A weary that reminds me tha

Learning from Saskatchewan’s HIV emergency

published: March, 22, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Hep B and C, As Prevention , Current Affairs, Treatment Guidelines -including when to start, General Health, Mental Health, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media

"...as a nurse, and as a human, I remain disappointed at what I perceive to be the lack of an adequate and equitable HIV response in Saskatchewan." From CATIE Blog, Susanne Nicolay shares the benefit of her 24-plus years' experience there.

Learning from Saskatchewan’s HIV emergency

Saskatchewan has led the country in the rate of new HIV infections and the proportion of people living with HIV since 2009. The HIV epidemic in this province is unique from other jurisdictions in Canada in that more than three-quarters of our new infections occur in people who use injection drugs (the Canadian average is less than 14%). The roots of public health challenges such as HIV and hepatitis C, however, go much deeper than addiction and substance abuse. They started long ago, and they

8 Questions about PrEP for guys

published: March, 20, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Gay Men, As Prevention , CATIE, Treatment Guidelines -including when to start, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media

From CATIE, authoritative answers to eight of the most frequently asked questions about pre-exposure prophylaxis (PrEP).

8 Questions about PrEP for guys

A word on language: People use different words to talk about their bodies and their genitals. Here we use medical words, such as penis, anus and vagina, to describe genitals. Some people may use other words, such as private parts, dick, ass and front hole. CATIE acknowledges and respects that people use words that they are most comfortable with. 1. What is PrEP?  PrEP is used by HIV-negative people to help prevent HIV transmission. PrEP stands for pre-exposure prophylaxis. It involves taki

New South Wales puts 9000 people on PrEP, achieves a one-third decline in new HIV infections

published: March, 20, 2018 Written by // Guest Authors - Revolving Door Categories // Activism, Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Guest Authors, Media

Successful appeal to state government got ‘cap’ lifted on PrEP demo trial. From AIDSmap, Gus Cairns reports.

New South Wales puts 9000 people on PrEP, achieves a one-third decline in new HIV infections

The state of New South Wales in Australia has seen a fall of one-third in diagnoses of recent HIV infection since it started its pre-exposure prophylaxis (PrEP) implementation project, EPIC-NSW (Expanded PrEP Implementation in the Community), the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) heard last week. Andrew Grulich of the Kirby Institute of the University of New South Wales told the conference that only two people who entered EPIC-NSW had been diagnosed wi

How much "PrEP-resistant" HIV is out there?

published: March, 12, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, Gay Men, As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Treatment, Revolving Door, Guest Authors, Media

From AIDSmap, Gus Cairns reports from the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018).

How much

A study presented at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) aims to quantify how many people with HIV there might be in the community who both have a detectable HIV viral load and also have significant resistance to tenofovir and emtricitabine, the two drugs currently used in pre-exposure prophylaxis (PrEP). The researchers, from the University of Washington in Seattle, found that in King County, which contains Seattle, no more than 0.3% of the l

Undetectable viral load: further talks with Sammy

published: March, 08, 2018 Written by // Kimutai Kemboi, Categories // Activism, African, Caribbean and Black, As Prevention , Kimutai Kemboi, Treatment Guidelines -including when to start, Health, International , Treatment, Media, Opinion Pieces

From Kenya, Kimutai Kemboi on the many benefits of adherence to antiretroviral therapy (ART).

Undetectable viral load: further talks with Sammy

I must say having a talk with Sammy (as I said, not his real name) was one of the most interesting discussion I have ever had with anyone. His questions were endless, as each response gave rise to more questions but I was happy coz everything he asked was very relevant. Sammy: This is very interesting. So you mean an undetectable person can be in an intimate relationship with a negative person without posing a threat to him or her? Kemboi: (looking at my cup of tea) Just a minute Sammy, my t

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

published: March, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Guest Authors, Media

From AIDSmap, Michael Carter and Keith Alcorn report on the Rakai Community Cohort Study.

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

The rate of new HIV infections has halved since 2011 in a Ugandan community following large increases in male circumcision, antiretroviral treatment and viral suppression, Frank Kagaayi of the Rakai Health Sciences Program told the Conference on Retroviruses and Opportunistic Infections in Boston on Tuesday. Dr Kagaayi was presenting results from the Rakai Community Cohort Study, focusing on repeat surveys of one fishing village with a very high prevalence and incidence of HIV infection. The

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

published: March, 07, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Health, Research, International , Revolving Door, Treatment, Guest Authors, Media

Five of eleven treated animals still remained virally suppressed at six months. From AIDSmap, Liz Highleyman reports.

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston. Monkeys that received both the antibody, known as PGT121, and the TLR7 agonist GS-9620 maintained an undetectable viral load withou

Undetectable viral load is a milestone in this journey.

published: March, 05, 2018 Written by // Kimutai Kemboi, Categories // Social Media, Activism, African, Caribbean and Black, As Prevention , Kimutai Kemboi, Treatment Guidelines -including when to start, Health, International , Treatment, Living with HIV, Media

From Kenya, Kimutai Kemboi spreads the word that undetectable equals untransmittable

Undetectable viral load is a milestone in this journey.

I had a conversation with this guy, Sammy (not his real name) and I feel I should share it so that other people learn the facts. Sammy: Hi Kim? (the short name of Kimutai) Kemboi: Hi to you bro, how is the going? Sammy: All is well, how about you? Kemboi: Everything is perfect, just up and down as a routine. Sammy: There is something that has been disturbing my mind for a while now and I have tried asking and researching but I am not convinced by the responses. That is why I thought of a

HIV pre-exposure drug approved for funding in B.C., but barriers remain

published: February, 28, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Health, Revolving Door, Treatment, Guest Authors, Media

From the Globe and Mail, Holly McKenzie-Sutter

HIV pre-exposure drug approved for funding in B.C., but barriers remain

ISTOCKPHOTO Oren Adamson received a prescription for pre-exposure prophylaxis treatment in July of last year. Also known as PrEP, the once daily pill is believed to reduce the risk of contracting HIV by more than 90 per cent. Health Canada approved PrEP in the form of the drug Truvada last year, but it has remained too expensive for many patients at $1,000 month. It's considerably cheaper – $70 – in the United States, prompting Mr. Adamson to drive from his home in Vancouver across the bo

Beyond donor dollars for health care: how Uganda is thinking outside the box

published: February, 27, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Activism, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, Revolving Door, Treatment, Guest Authors

From The Conversation, Henry Zakumumpa reports on how Uganda is closing its funding gap for the scale-up of antiretroviral treatment and service delivery

Beyond donor dollars for health care: how Uganda is thinking outside the box

Over the last 15 years, there’s been a rapid increase in the number of patients receiving HIV treatment in sub-Saharan Africa. This has largely depended on foreign aid, particularly from global aid organisations such as the President’s Emergency Plan for AIDS Relief (PEPFAR) and The Global Fund. Millions of lives have been saved and the quality of life of those living with HIV has been improved dramatically. In recent years there have been persistent reports of a decline in the amou

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

published: February, 26, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Health, International , Treatment, Revolving Door, Media, Guest Authors, Opinion Pieces

From AIDSmap, Gus Cairns reports on the PrEP In Europe Summit 2018

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam ten days ago, heard. Ignorance – among politicians, among healthcare workers, and among potential users of PrEP – was the main reason Europe lags far behind the USA in PrEP provision, despite there being a possibly more favourable climate in terms of p

On-demand PEP to prevent HIV infection

published: February, 23, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media

“HIV PEP-in-pocket (PIP)" designed to help those “who do not meet criteria for daily or on-demand PrEP" From CATIE, Sean R.Hosein reports.

On-demand PEP to prevent HIV infection

- Post-exposure prophylaxis (PEP) can prevent HIV infection up to 72 hours after exposure - To expedite initiation of PEP, two Toronto clinics prescribed the medication in advance - 13% of “PEP-in-pocket” prescriptions were filled, resulting in zero infections There are several options to reduce a person’s risk of becoming infected with HIV during sex. One option increasingly used in Canada and other high-income countries involves the use of a pill containing two anti-HIV medicines—

[12 3 4 5  >>